Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord ID
7percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified0%myelin oligodendrocyte glycoprotein (200 ul) 68733myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified37.5%myelin oligodendrocyte glycoprotein (200 ul) 68732myelin oligodendrocyte glycoprotein (200 ul)
7percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat10-D10Rat142)not specified71.4%myelin oligodendrocyte glycoprotein (200 ul) 68219myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified40%myelin oligodendrocyte glycoprotein (200 ul) 68216myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified30%myelin oligodendrocyte glycoprotein (200 ul) 68213myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified56.3%myelin oligodendrocyte glycoprotein (200 ul) 68210myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat6)not specified87.5%myelin oligodendrocyte glycoprotein (200 ul) 68207myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified37.5%myelin oligodendrocyte glycoprotein (200 ul) 68204myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified87.5%myelin oligodendrocyte glycoprotein (200 ul) 68201myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified70%myelin oligodendrocyte glycoprotein (200 ul) 68198myelin oligodendrocyte glycoprotein (200 ul)
12percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified8.3%myelin oligodendrocyte glycoprotein (200 ul) 68195myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified25%myelin oligodendrocyte glycoprotein (200 ul) 68231myelin oligodendrocyte glycoprotein (200 ul)
13percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified30.8%myelin oligodendrocyte glycoprotein (200 ul) 68228myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified81.3%myelin oligodendrocyte glycoprotein (200 ul) 68225myelin oligodendrocyte glycoprotein (200 ul)
13percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat12-D10Rat144)not specified38.5%myelin oligodendrocyte glycoprotein (200 ul) 68222myelin oligodendrocyte glycoprotein (200 ul)
6post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kininot specified13.3dmyelin oligodendrocyte glycoprotein (200 ul) 68731myelin oligodendrocyte glycoprotein (200 ul)
1post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kininot specified3dmyelin oligodendrocyte glycoprotein (200 ul) 68730myelin oligodendrocyte glycoprotein (200 ul)
6post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat10-D10Rat142)not specified13.5dmyelin oligodendrocyte glycoprotein (200 ul) 68218myelin oligodendrocyte glycoprotein (200 ul)
6post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat219-D10Rat29)not specified11.5dmyelin oligodendrocyte glycoprotein (200 ul) 68215myelin oligodendrocyte glycoprotein (200 ul)
4post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat15-D10Rat29)not specified8.7dmyelin oligodendrocyte glycoprotein (200 ul) 68212myelin oligodendrocyte glycoprotein (200 ul)
14post-insult time to onset of experimental autoimmune encephalomyelitisDA/ZtmKininot specified13.4dmyelin oligodendrocyte glycoprotein (200 ul) 68209myelin oligodendrocyte glycoprotein (200 ul)
8post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat6)not specified18.9dmyelin oligodendrocyte glycoprotein (200 ul) 68206myelin oligodendrocyte glycoprotein (200 ul)
5post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat15-D10Rat29)not specified13.4dmyelin oligodendrocyte glycoprotein (200 ul) 68203myelin oligodendrocyte glycoprotein (200 ul)
8post-insult time to onset of experimental autoimmune encephalomyelitisDA/ZtmKininot specified16.4dmyelin oligodendrocyte glycoprotein (200 ul) 68200myelin oligodendrocyte glycoprotein (200 ul)
8post-insult time to onset of experimental autoimmune encephalomyelitisDA/ZtmKininot specified13dmyelin oligodendrocyte glycoprotein (200 ul) 68197myelin oligodendrocyte glycoprotein (200 ul)
12post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat15-D10Rat29)not specified3.5dmyelin oligodendrocyte glycoprotein (200 ul) 68194myelin oligodendrocyte glycoprotein (200 ul)
13post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat219-D10Rat29)not specified7.4dmyelin oligodendrocyte glycoprotein (200 ul) 68230myelin oligodendrocyte glycoprotein (200 ul)
10post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat15-D10Rat29)not specified8.6dmyelin oligodendrocyte glycoprotein (200 ul) 68227myelin oligodendrocyte glycoprotein (200 ul)
14post-insult time to onset of experimental autoimmune encephalomyelitisDA/ZtmKininot specified18.5dmyelin oligodendrocyte glycoprotein (200 ul) 68224myelin oligodendrocyte glycoprotein (200 ul)
7post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat12-D10Rat144)not specified14.4dmyelin oligodendrocyte glycoprotein (200 ul) 68221myelin oligodendrocyte glycoprotein (200 ul)
8percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified12.5%myelin oligodendrocyte glycoprotein (200 ul) 68737myelin oligodendrocyte glycoprotein (200 ul)
7percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified0%myelin oligodendrocyte glycoprotein (200 ul) 68736myelin oligodendrocyte glycoprotein (200 ul)
10percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified0%myelin oligodendrocyte glycoprotein (200 ul) 68217myelin oligodendrocyte glycoprotein (200 ul)
10percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified0%myelin oligodendrocyte glycoprotein (200 ul) 68214myelin oligodendrocyte glycoprotein (200 ul)
16percentage of deaths in a study population during a period of timeDA/ZtmKininot specified43.75%myelin oligodendrocyte glycoprotein (200 ul) 68211myelin oligodendrocyte glycoprotein (200 ul)
8percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat2-D10Rat6)not specified25%myelin oligodendrocyte glycoprotein (200 ul) 68208myelin oligodendrocyte glycoprotein (200 ul)
8percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified12.5%myelin oligodendrocyte glycoprotein (200 ul) 68205myelin oligodendrocyte glycoprotein (200 ul)
8percentage of deaths in a study population during a period of timeDA/ZtmKininot specified25%myelin oligodendrocyte glycoprotein (200 ul) 68202myelin oligodendrocyte glycoprotein (200 ul)
10percentage of deaths in a study population during a period of timeDA/ZtmKininot specified0%myelin oligodendrocyte glycoprotein (200 ul) 68199myelin oligodendrocyte glycoprotein (200 ul)
12percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified0%myelin oligodendrocyte glycoprotein (200 ul) 68196myelin oligodendrocyte glycoprotein (200 ul)
16percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified18.75%myelin oligodendrocyte glycoprotein (200 ul) 68232myelin oligodendrocyte glycoprotein (200 ul)
13percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified15.4%myelin oligodendrocyte glycoprotein (200 ul) 68229myelin oligodendrocyte glycoprotein (200 ul)
16percentage of deaths in a study population during a period of timeDA/ZtmKininot specified0%myelin oligodendrocyte glycoprotein (200 ul) 68226myelin oligodendrocyte glycoprotein (200 ul)
13percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat12-D10Rat144)not specified15.4%myelin oligodendrocyte glycoprotein (200 ul) 68223myelin oligodendrocyte glycoprotein (200 ul)
7percentage of deaths in a study population during a period of timeDA.ACI-(D10Rat10-D10Rat142)not specified28.57%myelin oligodendrocyte glycoprotein (200 ul) 68220myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified75%myelin oligodendrocyte glycoprotein (200 ul) 68735myelin oligodendrocyte glycoprotein (200 ul)
7percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified14.3%myelin oligodendrocyte glycoprotein (200 ul) 68734myelin oligodendrocyte glycoprotein (200 ul)
13percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat12-D10Rat144)not specified53.8%myelin oligodendrocyte glycoprotein (200 ul) 67876myelin oligodendrocyte glycoprotein (200 ul)
7percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat10-D10Rat142)not specified85.7%myelin oligodendrocyte glycoprotein (200 ul) 67875myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified81.2%myelin oligodendrocyte glycoprotein (200 ul) 67874myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat219-D10Rat29)not specified60%myelin oligodendrocyte glycoprotein (200 ul) 67873myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat6)not specified100%myelin oligodendrocyte glycoprotein (200 ul) 67860myelin oligodendrocyte glycoprotein (200 ul)
13percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified76.9%myelin oligodendrocyte glycoprotein (200 ul) 67859myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified40%myelin oligodendrocyte glycoprotein (200 ul) 67856myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified62.5%myelin oligodendrocyte glycoprotein (200 ul) 67855myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified87.5%myelin oligodendrocyte glycoprotein (200 ul) 67853myelin oligodendrocyte glycoprotein (200 ul)
16percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified87.5%myelin oligodendrocyte glycoprotein (200 ul) 67852myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified100%myelin oligodendrocyte glycoprotein (200 ul) 67850myelin oligodendrocyte glycoprotein (200 ul)
10percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA/ZtmKininot specified80%myelin oligodendrocyte glycoprotein (200 ul) 67849myelin oligodendrocyte glycoprotein (200 ul)
12percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat15-D10Rat29)not specified33.3%myelin oligodendrocyte glycoprotein (200 ul) 67848myelin oligodendrocyte glycoprotein (200 ul)